TBH I can see why the market didn’t get too excited - generation of a stable line is one of those “important but unsexy” things that need doing, but are unlikely to cause a hike in the SP in the same way positive safety or efficacy data will.
However, 100% it’s something that would be of interest to anyone doing due diligence ahead of a potential partnership deal or takeover. People involved in that will understand the drop in risk more than an average retail investor IMHO.
Ann: Patrys Successfully Establishes PAT-DX1 Stable Cell Line, page-24
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1284114 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1116001 | 3 |
View Market Depth
| Last trade - 16.12pm 29/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable